Outcomes of Patients with Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil beyond the Second Line: A Multicenter Retrospective Study from Saudi Arabia

BACKGROUND: The outcome of patients with refractory metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil (FTD/TPI) beyond the second-line has not been studied in Saudi Arabia. Therefore, this multicenter retrospective analysis was conducted to evaluate the efficacy of FTD/TPI. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Alghamdi, Mohammed, Bazarbashi, Shouki, Mahrous, Mervat, Alshaer, Omar, Mostafa Gad, Ahmed, Aseafan, Mohamed, Abdelgelil, Mai, Alshabi, Redhwan Mohammed, Alghanmi, Hosam Ali, Naser, Nasser Ahmed, Al Hariri, Husam, ALHamad, Abdulaziz, Al-Saleh, Khalid, Abdel-Aziz, Nashwa, Elsamany, Sherif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485708/
https://www.ncbi.nlm.nih.gov/pubmed/36147443
http://dx.doi.org/10.1155/2022/3796783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485708/
https://www.ncbi.nlm.nih.gov/pubmed/36147443
http://dx.doi.org/10.1155/2022/3796783

Ejemplares similares